monday.com Ltd. has announced its third quarter financial results for 2026, showcasing significant growth and a strategic shift towards artificial intelligence (AI). The company reported a revenue of $377.5 million, reflecting a 19% increase year-over-year. This growth is attributed to the company's ongoing transformation into an AI-first organization, which is expected to shape its future direction and impact the broader prepackaged software industry.
Background
monday.com Ltd. operates in the prepackaged software sector, with its primary focus on providing AI-driven workspace solutions. The company trades on the Nasdaq under the ticker symbol MNDY. It is categorized as a large accelerated filer and has been active in the market with various filings, including a recent 6-K on November 9, 2026, detailing its third-quarter results.
What the Filing Says
The recent filing includes a press release titled “monday.com Announces Third Quarter 2026 Results.” The document highlights the company’s revenue growth and operational achievements, stating, “Our third quarter showed both the strength of our foundation and the work ahead.” It emphasizes the transition towards an AI-first strategy while acknowledging the operational challenges that come with such a significant evolution.
Impact
The results may influence various stakeholders, including investors, employees, and competitors in the prepackaged software industry. The reported growth in revenue and operating income suggests a positive trajectory for monday.com, which could impact investor confidence and employee morale. Competitors may also feel compelled to enhance their AI capabilities in response to monday.com’s strategic direction and financial performance.
What's Next
The filing does not specify what happens next, but the company is likely to continue focusing on its AI initiatives and may provide further updates in future filings.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










